Trials / Completed
CompletedNCT05385562
Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
Formulated Posterior Subtenon Triamcinolone (PSTA) Injection Versus Posterior Subtenon Triamcinolone Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone in the management of macular edema secondary to non-ischemic retinal vein occlusions, either central or branch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate | formulated with sodium hyaluronate and chondroitin sulfate |
| DRUG | Triamcinolone Acetonide alone | Triamcinolone Acetonide alone |
Timeline
- Start date
- 2020-01-02
- Primary completion
- 2022-05-01
- Completion
- 2022-05-10
- First posted
- 2022-05-23
- Last updated
- 2022-05-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05385562. Inclusion in this directory is not an endorsement.